These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 3023430

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Relationship between atrial natriuretic polypeptide and cyclic 3'5'-guanosine monophosphate in human plasma.
    Fujio N, Ohashi M, Nawata H, Kato K, Ibayashi H, Matsuo H.
    J Lab Clin Med; 1987 Jun; 109(6):706-10. PubMed ID: 3035037
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of physiological levels of atrial natriuretic peptide on hormone secretion: inhibition of angiotensin-induced aldosterone secretion and renin release in normal man.
    Cuneo RC, Espiner EA, Nicholls MG, Yandle TG, Livesey JH.
    J Clin Endocrinol Metab; 1987 Oct; 65(4):765-72. PubMed ID: 2821056
    [Abstract] [Full Text] [Related]

  • 7. Vasodilatory actions of alpha-human atrial natriuretic peptide and high Ca2+ effects in normal man.
    Fujita T, Ito Y, Noda H, Sato Y, Ando K, Kangawa K, Matsuo H.
    J Clin Invest; 1987 Sep; 80(3):832-40. PubMed ID: 3040808
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Plasma concentration of atrial natriuretic polypeptide in patients with atrial tachycardia.
    Hirata Y, Nozaki A, Toda I, Murakawa Y, Sugimoto T, Matsuoka H, Ishii M, Sugimoto T, Miyata A, Kangawa K.
    Jpn Heart J; 1987 Jan; 28(1):53-61. PubMed ID: 3037129
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The significance of cGMP and dopamine receptor on the natriuretic and hypotensive activities of synthetic atrial natriuretic polypeptide in essential hypertension].
    Mori K, Shigetomi S, Kohno H, Tosaki H, Kato K, Tanaka K, Haga H, Kin S, Fukuchi S.
    Nihon Naibunpi Gakkai Zasshi; 1990 Feb 20; 66(2):83-93. PubMed ID: 2158911
    [Abstract] [Full Text] [Related]

  • 14. Effects of acute water load, hypertonic saline infusion, and furosemide administration on atrial natriuretic peptide and vasopressin release in humans.
    Kimura T, Abe K, Ota K, Omata K, Shoji M, Kudo K, Matsui K, Inoue M, Yasujima M, Yoshinaga K.
    J Clin Endocrinol Metab; 1986 May 20; 62(5):1003-10. PubMed ID: 2937798
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Plasma kinetics of synthetic alpha-human atrial natriuretic peptide in man.
    Gnädinger MP, Lang RE, Hasler L, Uehlinger DE, Shaw S, Weidmann P.
    Miner Electrolyte Metab; 1986 May 20; 12(5-6):371-4. PubMed ID: 2949138
    [Abstract] [Full Text] [Related]

  • 17. Atrial natriuretic peptide and urinary cyclic guanosine monophosphate in patients with chronic heart failure.
    Abraham WT, Hensen J, Kim JK, Dürr J, Lesnefsky EJ, Groves BM, Schrier RW.
    J Am Soc Nephrol; 1992 Jun 20; 2(12):1697-703. PubMed ID: 1323337
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Permissive action of glucocorticoid substitution therapy on the effects of atrial natriuretic peptide (hANP) in patients with adrenocortical insufficiency.
    Damjancic P, Vierhapper H.
    Exp Clin Endocrinol; 1990 Aug 20; 95(3):315-21. PubMed ID: 2174002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.